Search Results 101-110 of 17343 for Teratogenic
Participation eligibility · This study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...
Participation eligibility · Any of the following because this study involves an agent that has known genotoxic, mutagenic, and teratogenic effects: · Pregnant ...
Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons. Nursing persons.
... teratogenic effects of which on the developing fetus and newborn are unknown. Pregnant persons; Nursing persons; Persons of childbearing potential or able to ...
Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...
* Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A pregnancy test is ...
Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs. A pregnancy test is required ...
Have an understanding that the study drug could have a potential teratogenic risk. Agree to abstain from donating blood while taking study drug therapy and ...
Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant women; Nursing women; Men or ...
For this reason and because PD-1 inhibitors as well as EZH2 inhibitors are known to be teratogenic, women of child-bearing potential and men must agree to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.